Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT00005235 · ClinicalTrials.gov registry record

Heart Rate Variability and Sudden Cardiac Death

A clinical trial of Cardiovascular Diseases and Heart Diseases, sponsored by Columbia University.

Completed
Registry status
715
Enrollment target
1
Study location

NCT00005235: Completed study of Cardiovascular Diseases and Heart Diseases, sponsored by Columbia University.

NCT00005235 is a study of Cardiovascular Diseases and Heart Diseases that has completed, run by Columbia University. The registered enrollment target is 715 participants, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT00005235, a study of Cardiovascular Diseases and Heart Diseases, has completed, sponsored by Columbia University.

COMPLETED
Registry status
715 participants
Enrollment target
1
Study location

Study Summary

To evaluate the ability of heart rate variability to identify myocardial infarction patients at high risk of dying, particularly from sudden cardiac death.

Study Locations (1)

New York

  • Columbia University - New York

Trial Details

FieldValue
Enrollment Target 715 participants
Start Date 1988-12
Est. Completion 1993-09
Columbia University

958 total trials

What the finished NCT00005235 record still lists

NCT00005235 is an observational study that tracks outcomes without assigning an intervention. The registered 715 participants enrollment target is mid-sized for trials with a published cap, below the 26,972-participant average among 300 other Cardiovascular Diseases trials with a reported enrollment target (97% lower).

The record links to 6 conditions, with Cardiovascular Diseases appearing as the primary indexed condition, and to 0 interventions.

NCT00005235 reports a single indexed study location in New York.

Frequently Asked Questions

What is clinical trial NCT00005235 about?

NCT00005235 is a clinical study titled "Heart Rate Variability and Sudden Cardiac Death". To evaluate the ability of heart rate variability to identify myocardial infarction patients at high risk of dying, particularly from sudden cardiac death.

What is the current status of trial NCT00005235?

This trial is currently completed. The enrollment target is 715 participants. The study started on 1988-12. Estimated completion is 1993-09.

What conditions does trial NCT00005235 study?

This clinical trial studies the following conditions: Cardiovascular Diseases, Heart Diseases, Myocardial Infarction, Coronary Disease, Death, Sudden, Cardiac.

Who is sponsoring clinical trial NCT00005235?

This trial is sponsored by Columbia University, which has 958 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT00005235 being conducted?

This trial has 1 study location across New York. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Cardiovascular Diseases

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Where NCT00005235's enrollment target sits among peer trials

715 77th of 300 higher than 224 of 300 other Cardiovascular Diseases trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other Cardiovascular Diseases trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04680000 · 716 participants · NA

    Chronic Pain Management In Primary Care Using Behavioral Health Consultants

  • NCT05208762 · 714 participants · Phase 1

    A Study of PF-08046054/SGN-PDL1V in Advanced Solid Tumors

  • NCT06758401 · 714 participants · Phase 3

    This is a Study to Learn About How the Combination of the Study Medicines Sigvotatug Vedotin Plus Pembrolizumab Works in People With Non-small Cell Lung Cancer With High Levels of PD-L1.

  • NCT04916327 · 720 participants · NA

    Examining the Impact of Exercise Training on Vascular Dysfunction in Individuals With Mental Health Disorders - Study 1

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT00005235, the US trial registry maintained by the National Library of Medicine. NCT00005235 (mid enrollment · single site footprint · completed) retrieved and formatted by PlainTrial, see methodology.